150 related articles for article (PubMed ID: 22268426)
1. Ibipinabant attenuates β-cell loss in male Zucker diabetic fatty rats independently of its effects on body weight.
Rohrbach K; Thomas MA; Glick S; Fung EN; Wang V; Watson L; Gregory P; Antel J; Pelleymounter MA
Diabetes Obes Metab; 2012 Jun; 14(6):555-64. PubMed ID: 22268426
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of a chronic treatment with rimonabant on pancreatic function and beta-cell morphology in Zucker Fatty rats.
Duvivier VF; Delafoy-Plasse L; Delion V; Lechevalier P; Le Bail JC; Guillot E; Pruniaux MP; Galzin AM
Eur J Pharmacol; 2009 Aug; 616(1-3):314-20. PubMed ID: 19482020
[TBL] [Abstract][Full Text] [Related]
3. Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats.
Feigh M; Andreassen KV; Neutzsky-Wulff AV; Petersen ST; Hansen C; Bay-Jensen AC; Henriksen JE; Beck-Nielsen H; Christiansen C; Henriksen K; Karsdal MA
Br J Pharmacol; 2012 Sep; 167(1):151-63. PubMed ID: 22506938
[TBL] [Abstract][Full Text] [Related]
4. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
5. TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats.
Ito R; Tsujihata Y; Matsuda-Nagasumi K; Mori I; Negoro N; Takeuchi K
Br J Pharmacol; 2013 Oct; 170(3):568-80. PubMed ID: 23848179
[TBL] [Abstract][Full Text] [Related]
6. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
[TBL] [Abstract][Full Text] [Related]
7. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
Alemzadeh R; Tushaus KM
Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
[TBL] [Abstract][Full Text] [Related]
8. Effects of the dual PPAR-α/γ agonist aleglitazar on glycaemic control and organ protection in the Zucker diabetic fatty rat.
Bénardeau A; Verry P; Atzpodien EA; Funk JM; Meyer M; Mizrahi J; Winter M; Wright MB; Uhles S; Sebokova E
Diabetes Obes Metab; 2013 Feb; 15(2):164-74. PubMed ID: 22958363
[TBL] [Abstract][Full Text] [Related]
9. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
10. Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats.
Trevaskis JL; Sacramento CB; Jouihan H; Ali S; Le Lay J; Oldham S; Bhagroo N; Boland BB; Cann J; Chang Y; O'Day T; Howard V; Reers C; Winzell MS; Smith DM; Feigh M; Barkholt P; Schreiter K; Austen M; Andag U; Thompson S; Jermutus L; Coghlan MP; Grimsby J; Dohrmann C; Rhodes CJ; Rondinone CM; Sharma A
Diabetes; 2017 Jul; 66(7):2007-2018. PubMed ID: 28408435
[TBL] [Abstract][Full Text] [Related]
11. Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function.
Paulsen SJ; Vrang N; Larsen LK; Larsen PJ; Jelsing J
J Anat; 2010 Nov; 217(5):624-30. PubMed ID: 20807269
[TBL] [Abstract][Full Text] [Related]
12. The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes.
Hjuler ST; Gydesen S; Andreassen KV; Karsdal MA; Henriksen K
J Pharmacol Exp Ther; 2017 Jul; 362(1):24-30. PubMed ID: 28438778
[TBL] [Abstract][Full Text] [Related]
13. Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes.
Poucher SM; Cheetham S; Francis J; Zinker B; Kirby M; Vickers SP
Diabetes Obes Metab; 2012 Oct; 14(10):918-26. PubMed ID: 22564773
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the effect of canagliflozin on renal glucose reabsorption and progression of hyperglycemia in zucker diabetic Fatty rats.
Kuriyama C; Xu JZ; Lee SP; Qi J; Kimata H; Kakimoto T; Nakayama K; Watanabe Y; Taniuchi N; Hikida K; Matsushita Y; Arakawa K; Saito A; Ueta K; Shiotani M
J Pharmacol Exp Ther; 2014 Nov; 351(2):423-31. PubMed ID: 25216746
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
Alemzadeh R; Fledelius C; Bodvarsdottir T; Sturis J
Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
George C; Lochner A; Huisamen B
J Ethnopharmacol; 2011 Sep; 137(1):298-304. PubMed ID: 21645608
[TBL] [Abstract][Full Text] [Related]
17. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARalpha/gamma agonist on glycaemic control in Zucker diabetic fatty rats.
Brand CL; Galsgaard ED; Tornehave D; Rømer J; Gotfredsen CF; Wassermann K; Knudsen LB; Vølund A; Sturis J
Diabetes Obes Metab; 2009 Aug; 11(8):795-803. PubMed ID: 19519868
[TBL] [Abstract][Full Text] [Related]
19. Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats.
Larsen PJ; Wulff EM; Gotfredsen CF; Brand CL; Sturis J; Vrang N; Knudsen LB; Lykkegaard K
Diabetes Obes Metab; 2008 Apr; 10(4):301-11. PubMed ID: 18333889
[TBL] [Abstract][Full Text] [Related]
20. KDT501, a derivative from hops, normalizes glucose metabolism and body weight in rodent models of diabetes.
Konda VR; Desai A; Darland G; Grayson N; Bland JS
PLoS One; 2014; 9(1):e87848. PubMed ID: 24498211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
